Investorideas.com newswire, breaking biotechnology and pharma news

Wednesday, April 17, 2024

Biopharma Stocks in Play - Palisade Bio, Inc. (Nasdaq: PALI) Soars on News it Demonstrated Bioactivation of PALI-2108 In Ex-Vivo Study

Biopharma Stocks in Play - Palisade Bio, Inc. (Nasdaq: PALI) Soars on News it Demonstrated Bioactivation of PALI-2108 In Ex-Vivo Study: Biopharma Stocks in Play - Palisade Bio, Inc. (Nasdaq: PALI) Soars on News it Demonstrated Bioactivation of PALI-2108 In Ex-Vivo Study

Pharma Stocks in Play - Jaguar Health, Inc. (NASDAQ: JAGX) Spikes on Volume of over 500 Million on News of Licensing FDA-Approved Oral Mucositis Product

Pharma Stocks in Play - Jaguar Health, Inc. (NASDAQ: JAGX) Spikes on Volume of over 500 Million on News of Licensing FDA-Approved Oral Mucositis Product: Pharma Stocks in Play - Jaguar Health, Inc. (NASDAQ: JAGX) Spikes on Volume of over 500 Million on News of Licensing FDA-Approved Oral Mucositis Product

Healthcare Stocks in Play - INVO Bioscience (Nasdaq: INVO) Soars on Fourth Quarter and Full Year 2023 Financial Results

Healthcare Stocks in Play - INVO Bioscience (Nasdaq: INVO) Soars on Fourth Quarter and Full Year 2023 Financial Results: Healthcare Stocks in Play - INVO Bioscience (Nasdaq: INVO) Soars on Fourth Quarter and Full Year 2023 Financial Results